Dr. Dan C. Belz

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine. Dr. Mccormack is currently accepting new patients.

Dr. Hansel is a pulmonary and critical care medicine physician. She is an expert in the diagnosis and treatment of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), and care of patients in the Medical ICU. Dr. Hansel is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Asthma, Bronchitis, and Endoscopy. Dr. Hansel is board certified in American Board Of Internal Medicine. Dr. Hansel is currently accepting new patients.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Sarcoidosis, Scleroderma, Systemic Sclerosis (SSc), and Lung Transplant. Dr. Lammi is board certified in American Board Of Internal Medicine. Dr. Lammi is currently accepting new patients.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lung Cancer, Endoscopy, and Advanced Bronchoscopy. Dr. Yarmus is currently accepting new patients.

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy. Dr. Lee is board certified in American Board Of Internal Medicine. Dr. Lee is currently accepting new patients.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Acute Interstitial Pneumonia. Dr. Wise is board certified in American Board Of Internal Medicine. Dr. Wise is currently accepting new patients.